Oct 3, 2019 06:21PM
Oct 3, 2019 06:21PM
Sep 25, 2019 08:25AM
Sep 25, 2019 08:25AM
Sep 11, 2019 05:50PM
Sep 11, 2019 05:50PM
Aug 30, 2019 08:02AM Novelion Therapeutics Provides Update Regarding Delisting from Nasdaq and Aegerion Bankruptcy Case
Aug 30, 2019 08:02AM
Jul 5, 2019 08:35AM
Jul 5, 2019 08:30AM
Jul 5, 2019 08:30AM
May 21, 2019 06:05AM
May 20, 2019 10:53PM
May 20, 2019 10:53PM Novelion Therapeutics Announces Subsidiary Aegerion Pharmaceuticals to Recapitalize Through Court Supervised Process In Which Amryt Pharma Plc Will Acquire 100% of Reorganized Stock of Aegerion
May 7, 2019 04:01PM
May 7, 2019 04:01PM
Mar 14, 2019 05:12PM
Mar 14, 2019 05:12PM
Feb 6, 2019 05:57AM
Feb 6, 2019 02:30AM
Feb 6, 2019 02:30AM Novelion Therapeutics Subsidiary Enters Into Licensing Agreement for JUXTAPID® in Japan
Dec 3, 2018 06:01PM
Nov 20, 2018 04:05PM
Nov 20, 2018 04:05PM
Nov 9, 2018 08:46AM
Nov 9, 2018 08:46AM
Nov 8, 2018 08:48AM
Nov 8, 2018 08:48AM Novelion Therapeutics Subsidiary Enters Into Term Loan Agreement and Novelion Provides Business Update
Aug 7, 2018 08:30AM
Aug 7, 2018 08:30AM
May 10, 2018 08:30AM
May 10, 2018 08:30AM
Mar 15, 2018 05:17PM
Mar 15, 2018 05:17PM
Dec 4, 2017 08:35AM Novelion Therapeutics (NVLN) Names Michael Price as SVP and CFO
Dec 4, 2017 08:30AM
Nov 9, 2017 08:28AM
Aug 8, 2017 07:00AM
May 9, 2017 07:00AM
Mar 15, 2017 07:00AM
Jan 9, 2017 07:41AM
Dec 5, 2016 08:30AM Aegerion Pharmaceuticals, a Subsidiary of Novelion Therapeutics, Enters into Agreement in Principle to Settle Class Action Shareholder Lawsuit

1,161,133 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All